REMI (Remedent) Days Payable: 1,700.24 (As of Dec. 2020)

What is Remedent Days Payable?

Remedent REMI +16.67% 12 Days Payable is 1,700.24 as of Dec. 2020. GuruFocus rates REMI with a GF Score™ of 12/100.

Remedent's average Accounts Payable for the three months ended in Dec. 2020 was $2.39 Mil. Remedent's Cost of Goods Sold for the three months ended in Dec. 2020 was $0.13 Mil. Hence, Remedent's Days Payable for the three months ended in Dec. 2020 was 1,700.24.

The historical rank and industry rank for Remedent's Days Payable or its related term are showing as below:

REMI's Days Payable is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 68.07
* Ranked among companies with meaningful Days Payable only.

Remedent's Days Payable declined from Dec. 2019 (2,061.38) to Dec. 2020 (1,700.24). It may suggest that Remedent accelerated paying its suppliers.

Remedent Days Payable Related Terms

Remedent Days Payable Historical Data

* Premium members only.

The historical data trend for Remedent's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remedent Days Payable Chart

Remedent Annual Data

Trend

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Days Payable

Get a 7-Day Free Trial

365.45

284.89

518.47

1,307.10

2,388.37

Remedent Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Days Payable	Get a 7-Day Free Trial															2,061.38	2,436.27	3,204.81	1,913.83	1,700.24

REMI vs SECI, RSCF, OZSC: Days Payable Comparison

For the Medical Instruments & Supplies subindustry, Remedent's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Remedent Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Remedent's Days Payable distribution charts can be found below:

* The bar in red indicates where Remedent's Days Payable falls into.

Save Embed

12GF Score

Remedent Inc REMI

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Remedent Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Remedent's Days Payable for the fiscal year that ended in Mar. 2020 is calculated as

	Days Payable (A: Mar. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2019 )	+	Accounts Payable (A: Mar. 2020 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2020 )	*	Days in Period
=	( (1.919	+	2.295)	/	2 )	/	0.322	*	365
=	2.107					/	0.322	*	365
=	2,388.37

Remedent's Days Payable for the quarter that ended in Dec. 2020 is calculated as:

	Days Payable (Q: Dec. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2020 )	+	Accounts Payable (Q: Dec. 2020 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2020 )	*	Days in Period
=	( (2.399	+	2.371)	/	2 )	/	0.128	*	365 / 4
=	2.385					/	0.128	*	365 / 4
=	1,700.24

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 1,700.24 mean?

Remedent (REMI) has a Days Payable of 1,700.24 as of Dec. 2020. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Remedent and its competitors.

Is Remedent's Days Payable too high?

Remedent's current Days Payable is 1,700.24. The Medical Devices & Instruments industry median Days Payable is 68.07. Remedent's value of 1,700.24 is 2397.8% above this industry median. Overall, Remedent has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Remedent's Days Payable compare to SECI and RSCF?

Remedent's Days Payable of 1,700.24 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 68.07. Remedent's value of 1,700.24 is 2397.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Medical Devices & Instruments company?

The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Remedent's current Days Payable of 1,700.24 is 2397.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Remedent and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Remedent's current Days Payable is 1,700.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Remedent stock overvalued right now?

Remedent (REMI) has a current Days Payable of 1,700.24. The current Days Payable is 1,700.24 and 2397.8% above the Medical Devices & Instruments industry median of 68.07. Remedent's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Remedent (REMI), the current Days Payable is 1,700.24 as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Remedent Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies SECI RSCF OZSC ASNB WHSI VLRXQ NURO ECIA POAI ELGX BDX ISRG XPAR:EL BAX OCSE:COLO B TSE:7741 XSWX:ALC TSE:4543 XPAR:DIM RMD

Address Zuiderlaan 1-3, Bus 8, Ghent, BEL, 9000

Website https://www.remedent.com

Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States.

12GF Score

Get the complete analysis for REMI

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View REMI Analysis

See Days Payable data for all stocks →